Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Therapeutic Gene Editing of HSCs Ex Vivo without in Vitro Culture Avoids Genotoxicity, Simplifies Procedures, and Preserves Efficiency and Stemness

Jing Zeng, My Anh Nguyen, Marioara-Felicia Ciuculescu, Esther Mintzer, Pengpeng Liu, Linda Yingqi Lin, Tolulope O Rosanwo, Archana Verma, Nola Neri, Stacy A. Maitland, Alden Richter, David G. Justus, Kendell Clement, Christian Brendel, Luca Pinello, John P Manis, Myriam Armant, Scot A. Wolfe, Daniel E. Bauer

Blood (2022) 140 (Supplement 1): 10671–10672.

https://doi.org/10.1182/blood-2022-169900

Published: 2022

Journal Articles

In Situ Characterization of Chromatin Landscape in Progression of Smoldering Precursor Stage to Multiple Myeloma

Mahshid Rahmat, Michael Vinyard, Romanos Sklavenitis-Pistofidis, Kendell Clement, Elizabeth D. Lightbody, Cody J. Boehner, Laura Hevenor, Jacqueline Perry, Gad Getz, Irene Ghobrial

Blood (2022) 140 (Supplement 1): 4222–4223.

https://doi.org/10.1182/blood-2022-167727

Published: 2022

Journal Articles

Identification of a Novel Epigenetic Mechanism of MYC Deregulation in Smoldering and Newly Diagnosed Multiple Myeloma Patients

Mahshid Rahmat, Kendell Clement, Romanos Sklavenitis-Pistofidis, Rohan Kodgule, Charles Fulco, Jean-Baptiste Alberge, Cody J. Boehner, Michael P. Agius, Elizabeth Morgan Kitzenberg, David Dorfman, Russell J. H. Ryan, Luca Pinello, Irene M. Ghobrial

Blood (2021) 138 (Supplement 1): 504.

https://doi.org/10.1182/blood-2021-150734

Published: 2021

Journal Articles

Multiplexed CRISPR In Vivo Editing of CLL Loss-of-Function Lesions Models Transformation of Chronic Lymphocytic Leukemia into Richter's Syndrome

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-137130

Published: 2020

Journal Articles

Interrogation of Individual CLL Loss-of-Function Lesions By CRISPR In Vivo Editing Reveals Common and Unique Pathway Alterations

Blood (2019) 134 (Supplement_1): 684.

https://doi.org/10.1182/blood-2019-127673

Published: 2019

Journal Articles

Distinct Evolutionary Patterns in Chronic Lymphocytic Leukemia (CLL) during Resistance to Graft-Versus-Leukemia (GvL)

Blood (2019) 134 (Supplement_1): 516.

https://doi.org/10.1182/blood-2019-129520

Published: 2019

Journal Articles

Highly Efficient Therapeutic Gene Editing of BCL11A enhancer in Human Hematopoietic Stem Cells from ß-Hemoglobinopathy Patients for Fetal Hemoglobin Induction

Blood (2018) 132 (Supplement 1): 3482.

https://doi.org/10.1182/blood-2018-99-119365

Published: 2018

Journal Articles

Clonal and Single Cell Dynamics of Resistance to Graft-Versus-Leukemia (GvL) in Chronic Lymphocytic Leukemia (CLL)

Pavan Bachireddy, MD, Nikolaos Barkas, PhD, Sachet A Shukla, PhD, Samuel Freeman, Liudmila Elagina, PhD, Vinhkhang N Nguyen, Kendell Clement, PhD, Ignaty Leshchiner, PhD, Jennifer R. Brown, MD PhD, Donna S Neuberg, ScD, Vincent T. Ho, MD, Robert J. Soiffer, MD, Jerome Ritz, MD PhD, Gad Getz, PhD, Edwin P. Alyea, III, MD, Peter Kharchenko, PhD, Catherine J. Wu, MD

Blood (2018) 132 (Supplement 1): 820.

https://doi.org/10.1182/blood-2018-99-116681

Published: 2018

Journal Articles

Single Cell Bisulfite Sequencing Defines Epigenetic Diversification in Chronic Lymphocytic Leukemia

Dan A. Landau, MD PhD, Kendell Clement, Hongcang Gu, Evan Biederstedt, MA, Divy Kangeyan, Steven Hill, Lili Wang, MD PhD, Martin Aryee, PhD, Andreas Gnirke, Alex Meissner, Catherine J Wu, MD

Blood (2016) 128 (22): 1047.

https://doi.org/10.1182/blood.V128.22.1047.1047

Published: 2016

Journal Articles

Loss of TET2 Function in Myelodysplastic Syndrome Results in Intragenic Hypermethylation and Alterations in mRNA Splicing

Allegra M Lord, Kendell Clement, Rebekka K. Schneider, MD, McConkey Marie, PhD, Michelle C. Chen, Ross L. Levine, MD, Ann Mullally, MD, Naomi Galili, PhD, Abdullah Mahmood Ali, PhD, Azra Raza, MD, Rafael Bejar, MD PhD, Alexander Meissner, PhD, Benjamin L. Ebert, MDPhD

Blood (2014) 124 (21): 775.

https://doi.org/10.1182/blood.V124.21.775.775

Published: 2014

Journal Articles

Increased Local Disorder of DNA Methylation Forms the Basis of High Intra-Leukemic Epigenetic Heterogeneity and Enhances CLL Evolution

Blood (2013) 122 (21): 596.

https://doi.org/10.1182/blood.V122.21.596.596

Published: 2013

NARROW

Therapeutic Gene Editing of HSCs Ex Vivo without in Vitro Culture Avoids Genotoxicity, Simplifies Procedures, and Preserves Efficiency and Stemness

In Situ Characterization of Chromatin Landscape in Progression of Smoldering Precursor Stage to Multiple Myeloma

Identification of a Novel Epigenetic Mechanism of MYC Deregulation in Smoldering and Newly Diagnosed Multiple Myeloma Patients

Multiplexed CRISPR In Vivo Editing of CLL Loss-of-Function Lesions Models Transformation of Chronic Lymphocytic Leukemia into Richter's Syndrome

Interrogation of Individual CLL Loss-of-Function Lesions By CRISPR In Vivo Editing Reveals Common and Unique Pathway Alterations

Distinct Evolutionary Patterns in Chronic Lymphocytic Leukemia (CLL) during Resistance to Graft-Versus-Leukemia (GvL)

Highly Efficient Therapeutic Gene Editing of BCL11A enhancer in Human Hematopoietic Stem Cells from ß-Hemoglobinopathy Patients for Fetal Hemoglobin Induction

Clonal and Single Cell Dynamics of Resistance to Graft-Versus-Leukemia (GvL) in Chronic Lymphocytic Leukemia (CLL)

Single Cell Bisulfite Sequencing Defines Epigenetic Diversification in Chronic Lymphocytic Leukemia

Loss of TET2 Function in Myelodysplastic Syndrome Results in Intragenic Hypermethylation and Alterations in mRNA Splicing

Increased Local Disorder of DNA Methylation Forms the Basis of High Intra-Leukemic Epigenetic Heterogeneity and Enhances CLL Evolution

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only